{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:42:04Z","timestamp":1740120124117,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T00:00:00Z","timestamp":1689984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T00:00:00Z","timestamp":1689984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s12185-023-03645-4","type":"journal-article","created":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T15:01:18Z","timestamp":1690038078000},"page":"450-461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Substitution of calcineurin inhibitors with corticosteroids after allogeneic hematopoietic cell transplantation"],"prefix":"10.1007","volume":"118","author":[{"given":"Shimpei","family":"Matsumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun-ichi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhei","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakatsu","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunto","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomu","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Misaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Gomyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Akahoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Machiko","family":"Kusuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Kameda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aki","family":"Tanihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Nakasone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Kako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4866-9307","authenticated-orcid":false,"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,22]]},"reference":[{"key":"3645_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1749-6632.1993.tb17137.x","volume":"696","author":"G Wiederrecht","year":"1993","unstructured":"Wiederrecht G, Lam E, Hung S, Martin M, Sigal N. The mechanism of action of FK-506 and cyclosporin A. Ann NY Acad Sci. 1993;696:9\u201319.","journal-title":"Ann NY Acad Sci"},{"key":"3645_CR2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/0167-5699(92)90111-J","volume":"13","author":"SL Schreiber","year":"1992","unstructured":"Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today. 1992;13:136\u201342.","journal-title":"Immunol Today"},{"key":"3645_CR3","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1056\/NEJM198912213212507","volume":"321","author":"BD Kahan","year":"1989","unstructured":"Kahan BD. Cyclosporine. N Engl J Med. 1989;321:1725\u201338.","journal-title":"N Engl J Med"},{"key":"3645_CR4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1399-0012.1994.tb00097.x","volume":"8","author":"GB Klintmalm","year":"1994","unstructured":"Klintmalm GB. FK 506: an update. Clin Transpl. 1994;8:207\u201310.","journal-title":"Clin Transpl"},{"key":"3645_CR5","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/j.1442-200X.1995.tb03386.x","volume":"37","author":"Y Ishida","year":"1995","unstructured":"Ishida Y, Matsuda H, Kida K. Effect of cyclosporin a on human bone marrow granulocyte-macrophage progenitors with anti-cancer agents. Acta Paediatr Jpn. 1995;37:610\u20133.","journal-title":"Acta Paediatr Jpn"},{"key":"3645_CR6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transpl. 2013;48:452\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"3645_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/bmt.2015.222","volume":"51","author":"Y Kanda","year":"2016","unstructured":"Kanda Y, Kobayashi T, Mori T, Tanaka M, Nakaseko C, Yokota A, et al. A randomized controlled trial of cyclosporine and tacrolimus with strict control of blood concentrations after unrelated bone marrow transplantation. Bone Marrow Transpl. 2016;51:103\u20139.","journal-title":"Bone Marrow Transpl"},{"key":"3645_CR8","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJM198409133111103","volume":"311","author":"BD Myers","year":"1984","unstructured":"Myers BD, Ross J, Newton L, Luetscher J, Perlroth M. Cyclosporine-associated chronic nephropathy. N Engl J Med. 1984;311:699\u2013705.","journal-title":"N Engl J Med"},{"key":"3645_CR9","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/S0140-6736(78)91970-0","volume":"2","author":"RY Calne","year":"1978","unstructured":"Calne RY, White DJ, Thiru S, Evans DB, McMaster P, Dunn DC, et al. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet. 1978;2:1323\u20137.","journal-title":"Lancet"},{"key":"3645_CR10","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(79)92440-1","volume":"2","author":"RY Calne","year":"1979","unstructured":"Calne RY, Rolles K, White DJ, Thiru S, Evans DB, McMaster P, et al. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet. 1979;2:1033\u20136.","journal-title":"Lancet"},{"key":"3645_CR11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2215\/CJN.04800908","volume":"4","author":"M Naesens","year":"2009","unstructured":"Naesens M, Kuypers DRJ, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol. 2009;4:481\u2013508.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3645_CR12","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1172\/JCI116440","volume":"91","author":"DM Lanese","year":"1993","unstructured":"Lanese DM, Conger JD. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J Clin Invest. 1993;91:2144\u20139.","journal-title":"J Clin Invest"},{"key":"3645_CR13","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1172\/JCI116777","volume":"92","author":"L De Nicola","year":"1993","unstructured":"De Nicola L, Thomson SC, Wead LM, Brown MR, Gabbai FB. Arginine feeding modifies cyclosporine nephrotoxicity in rats. J Clin Invest. 1993;92:1859\u201365.","journal-title":"J Clin Invest"},{"key":"3645_CR14","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/ki.1993.101","volume":"43","author":"P Ruggenenti","year":"1993","unstructured":"Ruggenenti P, Perico N, Mosconi L, Gaspari F, Benigni A, Amuchastegui CS, et al. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int. 1993;43:706\u201311.","journal-title":"Kidney Int"},{"key":"3645_CR15","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/j.1523-1755.2005.00472.x","volume":"68","author":"S Lamas","year":"2005","unstructured":"Lamas S. Cellular mechanisms of vascular injury mediated by calcineurin inhibitors. Kidney Int. 2005;68:898\u2013907.","journal-title":"Kidney Int"},{"key":"3645_CR16","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199009133231101","volume":"323","author":"U Scherrer","year":"1990","unstructured":"Scherrer U, Vissing SF, Morgan BJ, Rollins JA, Tindall RS, Ring S, et al. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med. 1990;323:693\u20139.","journal-title":"N Engl J Med"},{"key":"3645_CR17","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/ndt\/gfg515","volume":"19","author":"R Higgins","year":"2004","unstructured":"Higgins R, Ramaiyan K, Dasgupta T, Kanji H, Fletcher S, Lam F, et al. Hyponatraemia and hyperkalaemia are more frequent in renal transplant recipients treated with tacrolimus than with cyclosporin. Further evidence for differences between cyclosporin and tacrolimus nephrotoxicities. Nephrol Dial Transpl. 2004;19:444\u201350.","journal-title":"Nephrol Dial Transpl"},{"key":"3645_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13097","author":"J Tainio","year":"2018","unstructured":"Tainio J. Calcineurin inhibitor-associated electrolyte disturbances after pediatric renal transplantation: Could fludrocortisone therapy have a role? [Internet]. Pediatr Transpl. 2018. https:\/\/doi.org\/10.1111\/petr.13097.","journal-title":"Pediatr Transpl"},{"key":"3645_CR19","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/lt.21154","volume":"13","author":"MF Dawwas","year":"2007","unstructured":"Dawwas MF, Lewsey JD, Neuberger JM, Gimson AE. The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study. Liver Transpl. 2007;13:1115\u201324.","journal-title":"Liver Transpl"},{"key":"3645_CR20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","volume":"119","author":"M Jagasia","year":"2012","unstructured":"Jagasia M, Arora M, Flowers MED, Chao NJ, McCarthy PL, Cutler CS, et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood. 2012;119:296\u2013307.","journal-title":"Blood"},{"key":"3645_CR21","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.bbmt.2013.05.018","volume":"19","author":"AK Omer","year":"2013","unstructured":"Omer AK, Ziakas PD, Anagnostou T, Coughlin E, Kourkoumpetis T, McAfee SL, et al. Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience. Biol Blood Marrow Transpl. 2013;19:1190\u20136.","journal-title":"Biol Blood Marrow Transpl"},{"key":"3645_CR22","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","volume":"11","author":"VT Ho","year":"2005","unstructured":"Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M, et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2005;11:571\u20135.","journal-title":"Biol Blood Marrow Transpl"},{"key":"3645_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/tid.12345","volume":"17","author":"M Kikuchi","year":"2015","unstructured":"Kikuchi M, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, et al. Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2015;17:56\u201365.","journal-title":"Transpl Infect Dis"},{"key":"3645_CR24","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1016\/j.bbmt.2020.01.012","volume":"26","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Shi J, Luo Y, Gao F, Tan Y, Lai X, et al. calcineurin inhibitors replacement by Ruxolitinib as graft-versus-host disease prophylaxis for patients after allogeneic stem cell transplantation. Biol Blood Marrow Transpl. 2020;26:e128\u201333.","journal-title":"Biol Blood Marrow Transpl"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03645-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-023-03645-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03645-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T20:58:08Z","timestamp":1729803488000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-023-03645-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,22]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["3645"],"URL":"https:\/\/doi.org\/10.1007\/s12185-023-03645-4","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2023,7,22]]},"assertion":[{"value":"29 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board of Jichi Medical University Saitama Medical Center (Saitama, Japan). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"According to the Japanese ethics guideline of clinical studies, we provided information of this retrospective study on the website and enabled patients to be excluded from the study if they do not agree to use their data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"According to the Japanese ethics guideline of clinical studies, we provided information of this retrospective study on the website and enabled patients to be excluded from the study if they do not agree to use their data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}